P. Straten

发表

Large-scale detection of antigen-specific T cells using peptide-MHC-I multimers labeled with DNA barcodes

Z. Szallasi, A. Eklund, N. McGranahan, 2016, Nature Biotechnology.

Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimers

Ton N Schumacher, Sine Reker Hadrup, T. Schumacher, 2009, Nature Methods.

Parallel detection of antigen-specific T cell responses by combinatorial encoding of MHC multimers

Ton N Schumacher, Sine Reker Hadrup, Pia Kvistborg, 2012, Nature Protocols.

Intratumoral Interleukin-21 Increases Antitumor Immunity, Tumor-infiltrating CD8+ T-cell Density and Activity, and Enlarges Draining Lymph Nodes

K. Skak, P. Straten, N. Ødum, 2010, Journal of immunotherapy.

Spontaneous presence of FOXO3-specific T cells in cancer patients

I. Svane, Ö. Met, P. Straten, 2014, Oncoimmunology.

IFN-α primes T- and NK-cells for IL-15-mediated signaling and cytotoxicity.

R. Søkilde, T. Litman, C. Geisler, 2011, Molecular immunology.

BRAF inhibition improves tumor recognition by the immune system

M. Donia, I. Svane, P. Fagone, 2012, Oncoimmunology.

The antiapoptotic member of the Bcl-2 family Mcl-1 is a CTL target in cancer patients

J. Becker, P. Straten, M. Andersen, 2005, Leukemia.

Cancer cells become susceptible to natural killer cell killing after exposure to histone deacetylase inhibitors due to glycogen synthase kinase-3-dependent expression of MHC class I-related chain A and B.

M. T. Pedersen, L. Andresen, A. Woetmann, 2005, Cancer research.

Characterization of Spontaneous Immune Responses against Long Peptides Derived from Bcl-X(L) in Cancer Patients Using Elispot

I. Svane, P. Straten, S. K. Larsen, 2012, Cells.

Lack of toxicity of therapy-induced T cell responses against the universal tumour antigen survivin.

J. Becker, L. Pedersen, E. Bröcker, 2005, Vaccine.

Immunogenicity of Bcl-2 in patients with cancer.

J. Becker, E. Balslev, I. Svane, 2005, Blood.

Advances in Brief Spontaneous Cytotoxic T-Cell Responses against Survivin-derived MHC Class I-restricted T-Cell Epitopes in Situ As Well As ex Vivo in Cancer Patients 1

J. Becker, L. Pedersen, E. Bröcker, 2001 .

Unconventional cytokine profiles and development of T cell memory in long-term survivors after cancer vaccination

G. Gaudernack, J. Kyte, P. Straten, 2009, Cancer Immunology, Immunotherapy.

Interferon‐α induces marked alterations in circulating regulatory T cells, NK cell subsets, and dendritic cells in patients with JAK2V617F‐positive essential thrombocythemia and polycythemia vera

I. Svane, M. Jensen, H. Hasselbalch, 2016, European journal of haematology.

Immunogenicity of Constitutively Active V599EBRaf

D. Schadendorf, J. Becker, S. Ugurel, 2004, Cancer Research.

Spontaneous Immunity against Bcl-xL in Cancer Patients 1

J. Becker, P. Kvistborg, P. Straten, 2005, The Journal of Immunology.

Methods to improve adoptive T-cell therapy for melanoma: IFN-γ enhances anticancer responses of cell products for infusion.

M. Donia, I. Svane, P. Straten, 2013, The Journal of investigative dermatology.

HAGE, a cancer/testis antigen with potential for melanoma immunotherapy: identification of several MHC class I/II HAGE-derived immunogenic peptides

R. Rees, G. Pawelec, F. Lemonnier, 2007, Cancer Immunology, Immunotherapy.

Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial.

I. Svane, S. Hadrup, A. Berntsen, 2010, Cytotherapy.

Therapeutic Dendritic Cell Vaccination of Patients With Metastatic Renal Cell Carcinoma: A Clinical Phase 1/2 trial

I. Svane, M. Claesson, A. Berntsen, 2008, Journal of immunotherapy.

Title: Long-lasting complete responses in patients with metastatic melanoma after adoptive cell therapy with tumor-infiltrating lymphocytes and an attenuated IL-2 regimen

M. Donia, I. Svane, H. Hendel, 2016 .

Adoptive cell transfer in the treatment of metastatic melanoma.

J. Becker, P. Straten, 2009, The Journal of investigative dermatology.

Analysis of Vδ1 T cells in clinical grade melanoma-infiltrating lymphocytes

M. Donia, I. Svane, P. Straten, 2012, Oncoimmunology.

Self-reactive T cells: suppressing the suppressors

J. Becker, P. Straten, M. Andersen, 2014, Cancer Immunology, Immunotherapy.

Influence of Metronomic Cyclophosphamide and Interleukine-2 alone or Combined on Blood Regulatory T Cells in Patients with Advanced Malignant Melanoma Treated with Dendritic Cell Vaccines

I. Svane, P. Straten, M. Andersen, 2012 .

Increase of Circulating CD4+CD25highFoxp3+ Regulatory T Cells in Patients With Metastatic Renal Cell Carcinoma During Treatment With Dendritic Cell Vaccination and Low-Dose Interleukin-2

I. Svane, A. Berntsen, P. Straten, 2010, Journal of immunotherapy.

Expression of CD94/NKG2 subtypes on tumor-infiltrating lymphocytes in primary and metastatic melanoma.

J. Becker, E. Bröcker, J. Zeuthen, 2000, The Journal of investigative dermatology.

Inflammation induced PD-L1-specific T cells

Ö. Met, P. Straten, C. Bonefeld, 2019, Cell stress.

Long-lasting disease stabilization in the absence of toxicity in metastatic lung cancer patients vaccinated with an HLA-A2-restricted epitope derived from indoleamine 2,3 dioxygenase

I. Svane, R. Andersen, P. Straten, 2013, Journal of Immunotherapy for Cancer.

Cancer Therapy : Clinical Long-lasting Disease Stabilization in the Absence of Toxicity in Metastatic Lung Cancer Patients Vaccinated with an Epitope Derived from Indoleamine 2 , 3 Dioxygenase

I. Svane, R. Andersen, P. Straten, 2013 .

The Immune System Strikes Back: Cellular Immune Responses against Indoleamine 2,3-dioxygenase

J. Becker, T. Schumacher, I. Svane, 2009, PloS one.

Natural T-cell responses against minor histocompatibility antigen (mHag) HY following HLA-matched hematopoietic cell transplantation: what are the requirements for a ‘good’ mHag?

S. Hadrup, P. Straten, L. Vindeløv, 2008, Leukemia.

Reactivity of naive CD 4 1 CD 25 2 T cells against gut microflora in healthy mice

M. Claesson, P. Straten, M. Gad, 2006 .

Reactivity of naive CD4+CD25- T cells against gut microflora in healthy mice.

M. Claesson, P. Straten, M. Gad, 2006, International immunology.

Immunotherapy for metastatic colorectal cancer: Present status and new options

I. Svane, P. Straten, M. Andersen, 2012, Scandinavian journal of gastroenterology.

CD8 T-Cell Responses Against Cyclin B1

P. Straten, R. Andersen, M. Andersen, 2009, Clinical Cancer Research.

Peptide vaccination against multiple myeloma using peptides derived from anti-apoptotic proteins: a phase I trial.

I. Svane, N. Abildgaard, L. Knudsen, 2016, Stem cell investigation.

Tryptophan 2,3-dioxygenase (TDO)-reactive T cells differ in their functional characteristics in health and cancer

J. Becker, I. Svane, Ö. Met, 2015, Oncoimmunology.

Circulation and homing of melanoma‐reactive T cells to both cutaneous and visceral metastases after vaccination with monocyte‐derived dendritic cells

J. Becker, L. Pedersen, W. Hohenberger, 2004, International journal of cancer.

Accumulation of identical T cells in melanoma and vitiligo-like leukoderma.

J. Becker, P. Guldberg, E. Bröcker, 1999, The Journal of investigative dermatology.

Expanded T Cell Clonotypes Comprise High Numbers of Locally In Situ T Cell Responses Against Melanoma

Hansen, J. Becker, P. Guldberg, 1999 .

Induction of systemic CTL responses in melanoma patients by dendritic cell vaccination: Cessation of CTL responses is associated with disease progression

J. Becker, E. Bröcker, E. Kämpgen, 2001, International journal of cancer.

In situ cytokine therapy: redistribution of clonally expanded T cells

J. Becker, P. Guldberg, D. Schrama, 2001, European Journal of Immunology.

Longitudinal immune monitoring of patients receiving intratumoral injection of a MART-1 T-cell receptor-transduced cell line (C-Cure 709).

H. Schmidt, S. Hadrup, P. Straten, 2009, Cytotherapy.

Aberrant p27Kip1 promoter methylation in malignant melanoma

J. Bartek, J. Bártková, P. Guldberg, 2000, Oncogene.

Spontaneous T-cell responses against peptides derived from the Taxol resistance–associated gene-3 (TRAG-3) protein in cancer patients

J. Becker, I. Svane, P. Straten, 2005, Cancer Immunology, Immunotherapy.

Spontaneous cytotoxic T-Cell reactivity against indoleamine 2,3-dioxygenase-2.

I. Svane, P. Straten, R. Andersen, 2011, Cancer research.

Expression and function of Kv1.3 channel in malignant T cells in Sézary syndrome

T. Litman, B. K. Lundholt, Ö. Met, 2019, Oncotarget.

Brief report Increase in circulating CD4 (cid:1) CD25 (cid:1) Foxp3 (cid:1) T cells in patients with Philadelphia-negative chronic myeloproliferative neoplasms during treatment with IFN- (cid:2)

I. Svane, M. Jensen, H. Hasselbalch, 2011 .

Concurrent disruption of cell cycle associated genes in mantle cell lymphoma: a genotypic and phenotypic study of cyclin D1, p16, p15, p53 and pRb

P. Guldberg, K. Grønbæk, N. E. Hansen, 1998, Leukemia.

Comment on “Reduced Cytotoxic Function of Effector CD8+ T Cells Is Responsible for Indoleamine 2,3-Dioxygenase-Dependent Immune Suppression”

P. Straten, M. Andersen, R. Sørensen, 2009, The Journal of Immunology.

T-cell receptor clonotype mapping using denaturing gradient gel electrophoresis : analysis of clonal T-cell responses in melanoma.

J. Becker, P. Guldberg, J. Zeuthen, 2001, Methods in molecular medicine.

A Potential Role of Indoleamine 2,3-Dioxygenase–Specific T cells in Leishmania Vaccination

P. Straten, M. Andersen, 2011, The Journal of infectious diseases.

A TGFβRII frameshift mutation derived CTL epitope recognised by HLA-A2 restricted CD8+ T cells

I. Saeterdal, G. Gaudernack, P. Straten, 2001 .

CD40-Ligated Dendritic Cells Effectively Expand Melanoma-Specific CD8+ CTLs and CD4+ IFN-γ-Producing T Cells from Tumor-Infiltrating Lymphocytes1

J. Becker, E. Bröcker, P. Terheyden, 2000, The Journal of Immunology.

Defining the critical hurdles in cancer immunotherapy

Zhigang Tian, Sylvia Janetzki, Cedrik M Britten, 2011, Journal of Translational Medicine.

T-cell response against human malignant melanoma.

P. Straten, 1998 .

Tumor infiltrating lymphocytes in seminoma lesions comprise clonally expanded cytotoxic T cells

J. Becker, L. Pedersen, S. Hadrup, 2006, International journal of cancer.

A TGFβRII frameshift-mutation-derived CTL epitope recognised by HLA-A2-restricted CD8+ T cells

G. Gaudernack, P. Straten, I. Sæterdal, 2001, Cancer Immunology, Immunotherapy.

Antibody Stabilization of Peptide–MHC Multimers Reveals Functional T Cells Bearing Extremely Low-Affinity TCRs

M. Donia, I. Svane, A. Sewell, 2014, The Journal of Immunology.

Somatic Fas mutations in non-Hodgkin's lymphoma: association with extranodal disease and autoimmunity.

P. Guldberg, K. Grønbæk, N. E. Hansen, 1998, Blood.

Somatic mutation of the Peutz-Jeghers syndrome gene, LKB1/STK11, in malignant melanoma

P. Guldberg, J. Zeuthen, P. Straten, 1999, Oncogene.

RhoH is important for positive thymocyte selection and T-cell receptor signaling.

M. Sixt, J. Ellwart, B. Holzmann, 2007, Blood.

Towards discovery‐driven translational research in breast cancer

P. Guldberg, H. Mouridsen, I. Gromova, 2004, The FEBS journal.

The Universal Character of the Tumor-Associated Antigen Survivin

J. Becker, I. Svane, P. Straten, 2007, Clinical Cancer Research.

Identification of a cytotoxic T lymphocyte response to the apoptosis inhibitor protein survivin in cancer patients.

J. Becker, L. Pedersen, P. Straten, 2001, Cancer research.

Collagen density regulates the activity of tumor-infiltrating T cells

L. Grøntved, M. Donia, I. Svane, 2018, Journal of Immunotherapy for Cancer.

HLA‐B35‐restricted immune responses against survivin in cancer patients

J. Becker, I. Svane, P. Straten, 2004, International journal of cancer.

Identification of Novel Survivin-Derived CTL Epitopes with Different HLA-A-Restriction Profiles

Mads Hald Andersen, Jürgen C. Becker, J. Becker, 2004, Cancer biology & therapy.

A survivin specific T-cell clone from a breast cancer patient displays universal tumor cell lysis

I. Svane, P. Straten, M. Andersen, 2008, Cancer biology & therapy.

CD8 T-cell Responses against Cyclin B1 in Breast Cancer Patients with Tumors Overexpressing p53

E. Balslev, I. Svane, S. Hadrup, 2009, Clinical Cancer Research.

Pre-Vaccination Frequencies of Th17 Cells Correlate with Vaccine-Induced T-Cell Responses to Survivin-Derived Peptide Epitopes

J. Becker, P. Straten, M. Andersen, 2015, PloS one.

Natural CD4+ T-Cell Responses against Indoleamine 2,3-Dioxygenase

M. Donia, I. Svane, T. Klausen, 2012, PloS one.

The JAK2V617F mutation is a target for specific T cells in the JAK2V617F-positive myeloproliferative neoplasms

H. Hasselbalch, Ö. Met, P. Straten, 2017, Leukemia.

Bimodal ex vivo expansion of T cells from patients with head and neck squamous cell carcinoma: a prerequisite for adoptive cell transfer.

C. von Buchwald, I. Svane, M. Therkildsen, 2011, Cytotherapy.

Identification of an HLA-A3-restricted cytotoxic T lymphocyte (CTL) epitope from ML-IAP.

J. Becker, P. Straten, M. Andersen, 2004, The Journal of investigative dermatology.

Tumor-Produced Immune Regulating Factors

J. Becker, P. Straten, M. Andersen, 2013 .

5-Azacytidine treatment sensitizes tumor cells to T-cell mediated cytotoxicity and modulates NK cells in patients with myeloid malignancies

M. Treppendahl, I. Dufva, K. Grønbæk, 2014, Blood Cancer Journal.

Evidence for involvement of clonally expanded CD8+ T cells in anticancer immune responses in CLL patients following nonmyeloablative conditioning and hematopoietic cell transplantation

S. Hadrup, P. Straten, H. Madsen, 2005, Leukemia.

Detection and Characterization of αβ-T-Cell Clonality by Denaturing Gradient Gel Electrophoresis (DGGE)

P. Guldberg, J. Zeuthen, I. Saeterdal, 1998 .

Regulators of apoptosis: suitable targets for immune therapy of cancer

Mads Hald Andersen, Jürgen C. Becker, J. Becker, 2005, Nature Reviews Drug Discovery.

Characterization of a single peptide derived from cytochrome P450 1B1 that elicits spontaneous human leukocyte antigen (HLA)-A1 as well as HLA-B35 restricted CD8 T-cell responses in cancer patients.

I. Svane, S. Hadrup, P. Kvistborg, 2008, Human immunology.

Analysis of T cell receptor αβ variability in lymphocytes infiltrating melanoma primary tumours and metastatic lesions

J. Schøller, J. Zeuthen, K. Drzewiecki, 1994, Cancer Immunology, Immunotherapy.

The 1170 A–P single-nucleotide polymorphism (SNP) in the Her-2/neu protein (HER2) as a minor histocompatibility antigen (mHag)

P. Straten, R. Andersen, A. Letsch, 2009, Leukemia.

Generation of human-melanoma-specific T lymphocyte clones defining novel cytolytic targets with panels of newly established melanoma cell lines

J. Zeuthen, P. Straten, Li Li, 1995, Cancer Immunology, Immunotherapy.

Related Chain A and B − MHC Class I Dependent Expression of − to Glycogen Synthase Kinase-3 Killing after Exposure to Histone Deacetylase Inhibitors Due Cancer Cells Become Susceptible to Natural Killer Cell

M. T. Pedersen, L. Andresen, A. Woetmann, 2005 .

Immunotherapy Bridge 2016 and Melanoma Bridge 2016: meeting abstracts

C. Croce, L. Fattore, R. Mancini, 2017, Journal of Translational Medicine.

Data analysis as a source of variability of the HLA-peptide multimer assay: from manual gating to automated recognition of cell clusters

Cliburn Chan, Hans-Georg Rammensee, Cedrik M. Britten, 2015, Cancer Immunology, Immunotherapy.

Activation of preexisting T cell clones by targeted interleukin 2 therapy.

J. Becker, P. Guldberg, J. Zeuthen, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Tumor associated antigen specific T-cell populations identified in ex vivo expanded TIL cultures.

I. Svane, P. Kvistborg, P. Straten, 2012, Cellular immunology.

A TGF betaRII frameshift-mutation-derived CTL epitope recognised by HLA-A2-restricted CD8+ T cells.

I. Saeterdal, G. Gaudernack, P. Straten, 2001, Cancer immunology, immunotherapy : CII.

T-Cell Isolation and Propagation in vitro

P. Straten, M. Andersen, 2006 .

Differential expression of CD28 and CD94 / NKG2 on T cells with identical TCR beta variable regions in primary melanoma and sentinel lymph node

J. Becker, E. Bröcker, D. Schrama, 2000, European journal of immunology.

A promiscuous survivin-derived T-cell epitope restricted to the HLA-A3 super-type alleles.

I. Svane, P. Kvistborg, P. Straten, 2012, The Journal of investigative dermatology.

T cell recognition of novel shared breast cancer antigens is frequently observed in peripheral blood of breast cancer patients

I. Svane, A. Bentzen, S. Hadrup, 2019, Oncoimmunology.

Mcl-1 and anticancer vaccination: identification of an HLA-A2-restricted epitope

P. Straten, R. Andersen, M. Andersen, 2008, Leukemia.

Next-generation detection of antigen-responsive T cells using DNA barcode-labeled MHC-I 1 multimers

Z. Szallasi, A. Eklund, C. Swanton, 2016 .

Adoptive T-cell therapy (ACT) with TILs for metastatic melanoma: Clinical responses and durable persistence of anticancer responses in peripheral blood.

M. Donia, I. Svane, R. Andersen, 2013 .

Generation and characterization of GP‐100 peptide‐specific NK‐T cell clones

J. Myklebust, I. Saeterdal, G. Gaudernack, 1998, International journal of cancer.

The Expression of IL-21 Is Promoted by MEKK4 in Malignant T Cells and Associated with Increased Progression Risk in Cutaneous T-Cell Lymphoma.

D. Sasseville, C. Geisler, N. Mongan, 2016, The Journal of investigative dermatology.

HLA-A2-restricted survivin-derived T-cell responses.

P. Straten, M. Andersen, 2011, Vaccine.

Increase in circulating CD4⁺CD25⁺Foxp3⁺ T cells in patients with Philadelphia-negative chronic myeloproliferative neoplasms during treatment with IFN-α.

I. Svane, M. Jensen, H. Hasselbalch, 2011, Blood.

[Immunotherapy of cancer].

J. Gehl, H. Schmidt, H. von der Maase, 1976, Ugeskrift for laeger.

Association of a functional Indoleamine 2,3-dioxygenase 2 genotype with specific immune responses

T. Klausen, P. Straten, Rikke B. Holmgaard, 2012, Oncoimmunology.

Immune Risk Phenotypes and Associated Parameters in Very Old Humans: A Review of Findings in the Swedish NONA Immune Longitudinal Study

G. Pawelec, S. Hadrup, B. Johansson, 2007 .

Elderly Cytomegalovirus-Specific T Cells in the Very Number of Dysfunctional Predicting Mortality and an Increased CD 8 T Cells Reveal a Repertoire Shrinkage Longitudinal Studies of Clonally Expanded and

G. Pawelec, B. Johansson, P. Straten, 2006 .

Identification and characterization of survivin‐derived H‐2Kb‐restricted CTL epitopes

J. Becker, P. Straten, H. Voigt, 2009, European journal of immunology.

Expansion of circulating CD56bright natural killer cells in patients with JAK2‐positive chronic myeloproliferative neoplasms during treatment with interferon‐α

I. Svane, M. Jensen, H. Hasselbalch, 2015, European journal of haematology.

Identification of identical TCRs in primary melanoma lesions and tumor free corresponding sentinel lymph nodes

J. Becker, P. Guldberg, L. Pedersen, 2006, Cancer Immunology, Immunotherapy.

Modeling Metastatic Colonization in a Decellularized Organ Scaffold‐Based Perfusion Bioreactor

J. Erler, C. Madsen, O. Willacy, 2021, Advanced healthcare materials.

Preferential usage of T‐cell receptor αβ variable regions among tumor‐infiltrating lymphocytes in primary human malignant melanomas

J. Schøller, J. Zeuthen, K. Hou‐Jensen, 2007 .

Spontaneous cytotoxic T-cell responses against survivin-derived MHC class I-restricted T-cell epitopes in situ as well as ex vivo in cancer patients.

J. Becker, L. Pedersen, E. Bröcker, 2001, Cancer research.

Targeting of lymphotoxin-alpha to the tumor elicits an efficient immune response associated with induction of peripheral lymphoid-like tissue.

J. Becker, E. Bröcker, W. Fischer, 2001, Immunity.

Functional capacity of Mcl-1-specific cytotoxic T-cells

O. Nielsen, P. Straten, M. Andersen, 2006, Leukemia.

Cytokine fusion protein treatment.

J. Becker, E. Bröcker, D. Schrama, 2002, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

764 Expansion with IL-15 increases cytotoxicity of Vγ9Vδ2 T cells and is associated with higher levels of cytotoxic molecules and T-bet

P. Straten, Alberto Simões, Pia Aehnlich, 2020 .

Clonal T cell responses in tumor infiltrating lymphocytes from both regressive and progressive regions of primary human malignant melanoma.

J. Becker, E. Bröcker, J. Zeuthen, 1996, The Journal of clinical investigation.

CD19‐Chimeric Antigen Receptor T Cells for Treatment of Chronic Lymphocytic Leukaemia and Acute Lymphoblastic Leukaemia

P. Straten, C. Lorentzen, P. T. Straten, 2015, Scandinavian journal of immunology.

Identification of an HLA-A1 restricted CTL epitope from Mcl-1

J. Becker, P. Kvistborg, P. Straten, 2005, Leukemia.

Galectin-1 induces a tumor-associated macrophage phenotype and upregulates indoleamine 2,3-dioxygenase-1

S. Stowell, H. Wandall, S. Vakhrushev, 2023, iScience.

Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma.

P. Guldberg, J. Zeuthen, P. thor Straten, 1997, Cancer research.

Changes in Peripheral Blood Level of Regulatory T cells in Patients with Malignant Melanoma During Treatment with Dendritic Cell Vaccination and Low‐dose IL‐2

I. Svane, P. Straten, M. Brimnes, 2011, Scandinavian Journal of Immunology.

Oligoclonal T-cell receptor usage of melanocyte differentiation antigen-reactive T cells in stage IV melanoma patients.

J. Becker, L. Pedersen, D. Schrama, 2001, Cancer research.

The calreticulin (CALR) exon 9 mutations are promising targets for cancer immune therapy

I. Svane, H. Hasselbalch, Ö. Met, 2018, Leukemia.

Intratumoral Interleukin-21 Increases Antitumor Immunity, Tumor-infiltrating CD8+ T-cell Density and Activity, and Enlarges Draining Lymph Nodes

K. Skak, P. Straten, N. Ødum, 2010, Journal of immunotherapy.

Immunotherapy for metastatic colorectal cancer: Present status and new options

I. Svane, P. Straten, M. Andersen, 2012, Scandinavian journal of gastroenterology.

Characterization and Comparison of ‘Standard’ and ‘Young’ Tumour‐Infiltrating Lymphocytes for Adoptive Cell Therapy at a Danish Translational Research Institution

M. Donia, I. Svane, P. Straten, 2012, Scandinavian journal of immunology.

Title: Long-lasting complete responses in patients with metastatic melanoma after adoptive cell therapy with tumor-infiltrating lymphocytes and an attenuated IL-2 regimen

M. Donia, I. Svane, H. Hendel, 2016 .

The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays

A. Mackensen, Tania T. Køllgaard, C. Gouttefangeas, 2007, Cancer Immunology, Immunotherapy.